Ashvattha Therapeutics

Developer of nanomedicines for ophthalmology, neurology, and inflammatory diseases

placeRedwood City, California, United States calendar_todayFounded 2015 groups40 employees language avttx.com

Registered entities

Social engagement

Social engagement: 4K social following, 6 posts in the last 12 months — below the industry typical range.

Investor mix

13 investors on record; lead investors include Huadong Medicine, Tribe Capital, Natural Capital.

Investor typeCountShare
Venture capital969%
Other / undisclosed431%

Recent activity

8 Jan 2026
Leadership hire
Executive Chairman
22 Nov 2025
Leadership hire
Chief Medical Officer
17 Nov 2025
Event
Fefferies Global Healthcare Conference, Ophthalmology Innovation Source,FLORetina 2025 Congress, Eyenovate
Coming soon